VST BIO Corp
VST BIO Corp is a biotechnology company developing first-in-class antibody drugs for the treatment of inflammatory and cardiovascular diseases, including stroke and acute myocardial infarction, as well as sepsis.
Funding history
About VST BIO Corp
How much funding has VST BIO Corp raised?
VST BIO Corp has raised $60.8M in total funding. The most recent round was Series A.
Where is VST BIO Corp headquartered?
VST BIO Corp is headquartered in San Diego, CA.
What does VST BIO Corp do?
VST BIO Corp is a biotechnology company developing first-in-class antibody drugs for the treatment of inflammatory and cardiovascular diseases, including stroke and acute myocardial infarction, as well as sepsis.
What makes VST BIO Corp notable?
San Diego biologics company led by CEO Krisztina Zsebo, PhD, developing vascular biologic therapies for ischemic stroke and acute cardiovascular disease.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
